Infigratinib Impurity 1 | CAS 115619-00-6 - Request Quote
Infigratinib Impurity 1
| SZ CAT No: | SZ-I065003 |
| CAS No | 115619-00-6 |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Infigratinib Impurity 1 is chemically 1-Ethyl-4-(4-nitrophenyl)piperazine. Infigratinib Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Infigratinib Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Infigratinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 115619-00-6
Purchase 115619-00-6
Order 115619-00-6
Enquire 115619-00-6
price of 115619-00-6
115619-00-6 Supplier
115619-00-6 Manufacturer
115619-00-6 Exporter
buy high quality Infigratinib Impurity 1
Purchase Infigratinib Impurity 1
Infigratinib Impurity 1 suppliers
Infigratinib Impurity 1 manufacturers
Infigratinib Impurity 1 price
Order Infigratinib Impurity 1
Enquire Infigratinib Impurity 1
Infigratinib Impurity 1 cost
Infigratinib Impurity 1 Supplier
Infigratinib Impurity 1 Distributor
Infigratinib Impurity 1 for Method Validation
Infigratinib Reference Standard
Infigratinib Impurity 1 for ANDA Filing
Infigratinib Impurity 1 for Forced Degradation Studies
Infigratinib Impurity 1 Identification Standards
Infigratinib Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.